ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026)
ENvue Medical's (FEED) quarterly Net Income towards Common Stockholders came in at -$12.2 million in Q2 2026, down 2332.8% year-over-year from $544786.8 in Q2 2025, and up 46.23% quarter-over-quarter from -$22.6 million in Q1 2026.
Powered by 
Analysis
ENvue Medical (FEED) Net Income towards Common Stockholders (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Net Income towards Common Stockholders for 13 consecutive years, with -$12.2 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 2332.8% year-over-year to -$12.2 million in Q2 2026; TTM through Jun 2026 was -$49.2 million, a 924.54% decrease from a year earlier, with the FY2025 full-year figure at -$16.8 million, down 352.77% from the prior year.
- Net Income towards Common Stockholders was -$12.2 million for Q2 2026 at ENvue Medical, up from -$22.6 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at -$500000.0 in Q2 2025 and troughed at -$22.6 million in Q1 2026.
- A 5-year average of -$3.6 million and a median of -$1.1 million in 2023 frame the typical range for Net Income towards Common Stockholders.
- Across the five-year window, Net Income towards Common Stockholders soared 85.69% in 2022 and sank 2332.8% in 2026, its largest moves.
- Over 5 years, Net Income towards Common Stockholders stood at -$2.1 million in 2022, then surged by 60.51% to -$813000.0 in 2023, then sank by 76.01% to -$1.4 million in 2024, then plunged by 851.99% to -$13.6 million in 2025, then increased by 10.71% to -$12.2 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$12.2 million (Q2 2026), -$22.6 million (Q1 2026), and -$13.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 907.00 Mn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 201.00 Mn |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | -12.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.16 Mn |
| Mar 31, 2026 | -22.62 Mn |
| Dec 31, 2025 | -13.62 Mn |
| Sep 30, 2025 | -780,000.00 |
| Jun 30, 2025 | -500,000.00 |
| Mar 31, 2025 | -1.87 Mn |
| Dec 31, 2024 | -1.43 Mn |
| Sep 30, 2024 | -998,000.00 |
| Jun 30, 2024 | -688,000.00 |
| Mar 31, 2024 | -588,000.00 |
| Dec 31, 2023 | -813,000.00 |
| Sep 30, 2023 | -727,000.00 |
| Jun 30, 2023 | -1.07 Mn |
| Mar 31, 2023 | -1.10 Mn |
| Dec 31, 2022 | -2.06 Mn |
| Sep 30, 2022 | -955,000.00 |
| Jun 30, 2022 | -1.30 Mn |
| Mar 31, 2022 | -1.13 Mn |
| Dec 31, 2021 | -2.47 Mn |
| Sep 30, 2021 | -6.67 Mn |